We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002475:SZSELuxshare Precision Industry Co., Ltd. Analysis

Data as of 2026-07-27 - not real-time

CN¥61.03

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Luxshare Precision is trading near its short‑term moving average while sitting below the medium‑term average, suggesting a neutral price stance. The RSI is below the 50‑point midpoint, reinforcing a lack of strong momentum, and the MACD histogram has turned slightly positive, hinting at a modest bullish bias. Fundamentals show robust revenue growth and a forward earnings multiple that is tighter than the trailing multiple, yet the discounted cash‑flow model places intrinsic value well below the current market price, indicating an overvaluation gap. The company enjoys a strong analyst consensus of a strong‑buy, low dividend payout, and a solid cash balance, but a high debt‑to‑equity ratio and negative free cash flow raise concerns about long‑term financial flexibility. Volume has been tapering, and volatility remains elevated, adding to the short‑term uncertainty.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price hovering around the short‑term average with limited momentum
  • decreasing trading volume signaling reduced short‑term interest
  • proximity to a technical support level that offers downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strong revenue growth and improving forward earnings multiple
  • analyst consensus of strong‑buy and attractive upside potential
  • low dividend payout supporting earnings retention for growth

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • exposure to expanding automotive and consumer electronics markets
  • high debt load and negative free cash flow limiting financial flexibility
  • valuation premium relative to intrinsic estimates, suggesting caution

Key Metrics & Analysis

Financial Health

Revenue Growth35.80%
Profit Margin4.86%
P/E Ratio26.2
ROE19.02%
ROA3.07%
Debt/Equity122.77
P/B Ratio5.0
Op. Cash FlowCN¥16.9B
Free Cash FlowCN¥-15037969408
Industry P/E32.9

Technical Analysis

TrendNeutral
RSI46.5
SupportCN¥55.03
ResistanceCN¥70.88
MA 20CN¥61.86
MA 50CN¥66.86
MA 200CN¥59.90
MACDBullish
VolumeDecreasing
Fear & Greed Index88.25

Valuation

Fair ValueCN¥47.24
Target PriceCN¥75.25
Upside/Downside23.31%
GradeOvervalued
TypeGrowth
Dividend Yield0.49%

Risk Assessment

Beta0.49
Volatility72.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.